2003Humana Press eBooksRequires access

In Vitro Matrigel Angiogenesis Assays

M. Lourdes Ponce

Open publisher page 39 citations

Abstract

A variety of in vivo and in vitro methods have been used to study angiogenesis, the process of blood vessel formation. Two widely accepted but technically difficult assays include the cornea implant assay and the chick chorioallantoic membrane assay. The cornea assay requires special equipment and a skilled person to implant beads containing the test compound in the eyes of animals; only a small number of samples can be tested due to cost and time. The chorioallantoic membrane assay requires a large number of samples on account of the variability of the system and its difficulty in quantitation. In our laboratory, we have developed a quick and highly reliable method for testing numerous compounds for angiogenic and/or antiangiogenic activity. The method is based on the differentiation of ECs on a basement membrane matrix, Matrigel, derived from the Engelbreth-Holm-Swarm tumor (1). ECs from human umbilical cords as well as from other sources differentiate and form capillary-like structures on Matrigel in the presence of 10% bovine calf serum (BCS) and 0.1 mg/mL of endothelial cell growth supplement (ECGS) (2), which is a mixture of both acidic and basic fibroblast growth factor (Fig. 1, Panel C). The formation of tube-like vessels under these conditions can be used to assess compounds that either inhibit or stimulate angiogenesis.

About this research paper

What this paper is about

A variety of in vivo and in vitro methods have been used to study angiogenesis, the process of blood vessel formation. Two widely accepted but technically difficult assays include the cornea implant assay and the chick chorioallantoic membrane assay. The cornea assay requires special equipment and a skilled person to implant beads containing the test compound in the eyes of animals; only a small number of samples can be tested due to cost and time. The chorioallantoic membrane assay requires a large number of samples on account of the variability of the system and its difficulty in quantitation. In our laboratory, we have developed a quick and highly reliable method for testing numerous compounds for angiogenic and/or antiangiogenic activity. The method is based on the differentiation of ECs on a basement membrane matrix, Matrigel, derived from the Engelbreth-Holm-Swarm tumor (1). ECs from human umbilical cords as well as from other sources differentiate and form capillary-like structures on Matrigel in the presence of 10% bovine calf serum (BCS) and 0.1 mg/mL of endothelial cell growth supplement (ECGS) (2), which is a mixture of both acidic and basic fibroblast growth factor (Fig. 1, Panel C). The formation of tube-like vessels under these conditions can be used to assess compounds that either inhibit or stimulate angiogenesis.

Why it matters

OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A variety of in vivo and in vitro methods have been used to study angiogenesis, the process of blood vessel formation. Two widely accepted but technically difficult assays include the cornea implant assay and the chick chorioallantoic membrane assay. The cornea assay requires special equipment and a skilled person to implant beads containing the test compound in the eyes of animals; only a small number of samples can be tested due to cost and time. The chorioallantoic membrane assay requires a large number of samples on account of the variability of the system and its difficulty in quantitation. In our laboratory, we have developed a quick and highly reliable method for testing numerous compounds for angiogenic and/or antiangiogenic activity. The method is based on the differentiation of ECs on a basement membrane matrix, Matrigel, derived from the Engelbreth-Holm-Swarm tumor (1). ECs from human umbilical cords as well as from other sources differentiate and form capillary-like structures on Matrigel in the presence of 10% bovine calf serum (BCS) and 0.1 mg/mL of endothelial cell growth supplement (ECGS) (2), which is a mixture of both acidic and basic fibroblast growth factor (Fig. 1, Panel C). The formation of tube-like vessels under these conditions can be used to assess compounds that either inhibit or stimulate angiogenesis.

Key concepts: Matrigel, Chorioallantoic membrane, Angiogenesis, Basement membrane, In vivo, Laboratory flask, In vitro, Neovascularization

Related papers

Back to paper searchBrowse research topicsOriginal source
In Vitro Matrigel Angiogenesis Assays — Research Paper | ScholarLens